Data as of Sep 19
| +0.03 / +3.00%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 5.87, with a high estimate of 5.87 and a low estimate of 5.87. The median estimate represents a +469.84% increase from the last price of 1.03.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.